Meropenem - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for meropenem and what is the scope of freedom to operate?
Meropenem
is the generic ingredient in four branded drugs marketed by Acs Dobfar, Acs Dobfar Spa, Amneal Pharms, Brooks Steriscience, Daewoong Pharm Co, Eugia Pharma, Gland, Hospira Inc, Hq Spclt Pharma, Qilu, Sandoz, Savior Lifetec Corp, Pfizer, B Braun Medical Inc, and Rempex, and is included in sixteen NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are thirty-two drug master file entries for meropenem. Fifteen suppliers are listed for this compound.
Summary for meropenem
US Patents: | 7 |
Tradenames: | 4 |
Applicants: | 15 |
NDAs: | 16 |
Drug Master File Entries: | 32 |
Finished Product Suppliers / Packagers: | 15 |
Raw Ingredient (Bulk) Api Vendors: | 84 |
Clinical Trials: | 137 |
Patent Applications: | 5,925 |
Drug Prices: | Drug price trends for meropenem |
What excipients (inactive ingredients) are in meropenem? | meropenem excipients list |
DailyMed Link: | meropenem at DailyMed |
Recent Clinical Trials for meropenem
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Scandinavian Critical Care Trials Group | Phase 4 |
Sheba Medical Center | Phase 4 |
Monaldi Hospital | Phase 4 |
Pharmacology for meropenem
Drug Class | Penem Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for meropenem
US Patents and Regulatory Information for meropenem
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Savior Lifetec Corp | MEROPENEM | meropenem | INJECTABLE;INJECTION | 206086-001 | Apr 19, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Gland | MEROPENEM | meropenem | INJECTABLE;INJECTION | 206141-002 | Jun 8, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Gland | MEROPENEM | meropenem | INJECTABLE;INJECTION | 206141-001 | Jun 8, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Brooks Steriscience | MEROPENEM | meropenem | INJECTABLE;INJECTION | 216154-002 | Aug 18, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Rempex | VABOMERE | meropenem; vaborbactam | POWDER;INTRAVENOUS | 209776-001 | Aug 29, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Hq Spclt Pharma | MEROPENEM | meropenem | INJECTABLE;INJECTION | 210773-002 | Aug 16, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for meropenem
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | MERREM | meropenem | INJECTABLE;INJECTION | 050706-001 | Jun 21, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | MERREM | meropenem | INJECTABLE;INJECTION | 050706-003 | Jun 21, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.